DK3113793T3 - Dna-vektor og transformerede tumorcellevacciner - Google Patents
Dna-vektor og transformerede tumorcellevacciner Download PDFInfo
- Publication number
- DK3113793T3 DK3113793T3 DK15712211.0T DK15712211T DK3113793T3 DK 3113793 T3 DK3113793 T3 DK 3113793T3 DK 15712211 T DK15712211 T DK 15712211T DK 3113793 T3 DK3113793 T3 DK 3113793T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumor cell
- dna vector
- cell vaccines
- transformed tumor
- transformed
- Prior art date
Links
- 229940030325 tumor cell vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461948980P | 2014-03-06 | 2014-03-06 | |
PCT/US2015/018688 WO2015134577A1 (en) | 2014-03-06 | 2015-03-04 | Dna vector and transformed tumor cell vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3113793T3 true DK3113793T3 (da) | 2021-01-18 |
Family
ID=52737394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15712211.0T DK3113793T3 (da) | 2014-03-06 | 2015-03-04 | Dna-vektor og transformerede tumorcellevacciner |
Country Status (4)
Country | Link |
---|---|
US (2) | US9555088B2 (da) |
EP (1) | EP3113793B1 (da) |
DK (1) | DK3113793T3 (da) |
WO (1) | WO2015134577A1 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016168361A1 (en) * | 2015-04-14 | 2016-10-20 | Polynoma, Llc | Polyvalent vaccines and combination therapy for the treatment of melanoma |
CA2985087C (en) * | 2015-05-19 | 2021-02-16 | Morphogenesis, Inc. | Cancer vaccine comprising mrna encoding a m-like-protein |
US10682401B2 (en) | 2015-05-19 | 2020-06-16 | Morphogenesis, Inc. | Multi-indication mRNA cancer immunotherapy |
EP3618856A4 (en) * | 2017-05-01 | 2021-02-24 | Morphogenesis, Inc. | MULTI-INDICATION RNA-BASED ANTI-CANCER IMMUNOTHERAPY |
JP2020520665A (ja) | 2017-05-24 | 2020-07-16 | ノバルティス アーゲー | 抗体−サイトカイングラフト化タンパク質及び癌の治療における使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7795020B2 (en) | 1998-01-14 | 2010-09-14 | Morphogenesis, Inc. | Tumor cell vaccines |
WO1999036433A2 (en) | 1998-01-14 | 1999-07-22 | Morphogenesis, Inc. | Materials and methods for treating oncological disease |
US7348015B2 (en) | 1998-01-14 | 2008-03-25 | Morphogenesis, Inc. | Antigen modified cancer cell vaccines for cancer therapy |
-
2015
- 2015-03-04 US US15/110,248 patent/US9555088B2/en active Active
- 2015-03-04 WO PCT/US2015/018688 patent/WO2015134577A1/en active Application Filing
- 2015-03-04 EP EP15712211.0A patent/EP3113793B1/en active Active
- 2015-03-04 DK DK15712211.0T patent/DK3113793T3/da active
-
2017
- 2017-01-30 US US15/418,798 patent/US9839680B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9555088B2 (en) | 2017-01-31 |
WO2015134577A1 (en) | 2015-09-11 |
EP3113793B1 (en) | 2020-11-18 |
EP3113793A1 (en) | 2017-01-11 |
US20160361400A1 (en) | 2016-12-15 |
US9839680B2 (en) | 2017-12-12 |
US20170136109A1 (en) | 2017-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261621A (en) | Genome edited immune effector cells | |
DK3597742T3 (da) | Car-udtrykkende vektor og car-udtrykkende t-celler | |
DK3134131T3 (en) | Nucleic acid vaccines | |
DK3229838T3 (da) | Anti-C10orf54-antistoffer og anvendelser deraf | |
HUE053101T2 (hu) | Javított T-sejt-készítmények | |
DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
SG11201605906UA (en) | Muscle-specific nucleic acid regulatory elements and methods and use thereof | |
DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
DK3237418T3 (da) | Triazolopyrimidinforbindelser og anvendelser deraf | |
DK3215147T3 (da) | Neurodæmpende norketamin-forbindelser og fremgangsmåder | |
DK3235830T3 (da) | Interleukin-15-proteinkompleks og anvendelse deraf | |
DK3757206T3 (da) | Transduktionsfremgangsmåde og cellebehandling | |
DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
DK3198009T3 (da) | Onkolytiske tumorvira og anvendelsesfremgangsmåder | |
DK3101760T3 (da) | Opladningsfremgangsmåde og system | |
DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
DK3240892T3 (da) | Rpe-cellepopulationer og fremgangsmåder til dannelse deraf | |
DK3131577T3 (da) | Modificerede værtsceller og anvendelser deraf | |
DK3100050T3 (da) | Immobiliserede proteiner og anvendelse deraf | |
DK3233105T3 (da) | Hidtil ukendt kombination og anvendelse | |
KR20180084747A (ko) | Galgt2 유전자 치료 방법 및 물질 | |
DK3837970T3 (da) | Herbicidtolerancegener og fremgangsmåder til anvendelse deraf | |
DK3113793T3 (da) | Dna-vektor og transformerede tumorcellevacciner | |
DK3158058T3 (da) | Fusionsproteiner og bruger deraf | |
DK3107376T3 (da) | Svampelinje b12998-s39 og fremgangsmåder dertil og anvendelser herfor |